Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K36/00 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.20040009245Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS)
US 15.01.2004
Int.Class A01N 25/00
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
25Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Appl.No 10429077 Applicant Inhalation, Inc. Inventor Vail, III William Banning

Concentrated vapors from botanical essential oils are inhaled to prevent, treat and cure infections of the respiratory pathogens causing Severe Acute Respiratory Syndrome (“SARS”). These vapors are inhaled as a practical method to reduce the risks of infection by the pathogens causing SARS in crowded public places. These vapors are also inhaled as a practical method to reduce the risks of infection by unknown, and unpredictable, respiratory pathogens that may be present in public places. The essential oils have antiseptic properties, are safe to inhale, and include, but are not limited to, the essential oils from Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus citriodora, and Eucalyptus radiata. Convenient hand-held inhaler apparatus are provided for the inhalation of concentrated vapors from the antiseptic essential oils and other substances. The antiseptic essential oils have selected antiviral, antibacterial, and antifungal properties.

2.20080038382Extracts of Scutellaria for the Treatment of Sars
US 14.02.2008
Int.Class A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
Appl.No 10590287 Applicant ZHONG SHOUMING Inventor Zhong Shouming

The present invention relates to pharmaceutical compositions having antiviral activity against Coronavirus, and more particularly against those viruses responsible for Severe Acute Respiratory Syndrome (SARS). In a preferred embodiment it comprises a total standardized extract of a Scutellariae spp.

3.20060178341Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 inhibiting the swine influenza (SIV) and transmissible gastroenteritis coronavirus (tgev)
US 10.08.2006
Int.Class A61K 31/716
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
716Glucans
Appl.No 10561714 Applicant MOON WON KOOK Inventor Moon Won Kook

The present invention relates to the soluble glucan oligomer having a M.W. ranging from 1,000 to 10,000 prepared by treating insoluble beta-glucan isolated the cell wall of yeast variant IS2 with commercially available beta-glucan hydrolyzing enzymes. The soluble glucan oligomer showed potent efficacy on inhibiting activity of influenza virus and transmissible gastroenteritis coronavirus, therefore, it can be used as the therapeutics or health care food for treating and preventing mammal's diseases caused by the infection of influenza virus and transmissible gastroenteritis coronavirus.

4.2010090066ANTI-SARS CORONAVIRUS AGENT AND PRODUCT CONTAINING ANTI-SARS CORONAVIRUS AGENT
JP 22.04.2010
Int.Class A61K 36/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
Appl.No 2008262200 Applicant POKKA CORP Inventor FUKUMOTO SHUICHI

PROBLEM TO BE SOLVED: To provide an anti-SARS coronavirus agent having excellent anti-SARS coronavirus action and a product containing the anti-SARS coronavirus agent.

SOLUTION: The anti-SARS coronavirus agent contains, as active components, a guava extract extracted by using an extraction solvent containing at least one kind of solvent selected from water and hydrophilic organic solvents as a main component, and ascorbic acids.

COPYRIGHT: (C)2010,JPO&INPIT

5.1020060058516COMPOSITION FOR TREATING CORONAVIRUS INFECTION DISEASES COMPRISING EXTRACT OF HOUTTUYNIA CORDATA THUNBERG
KR 30.05.2006
Int.Class A61K 36/78
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
78Saururaceae (Lizard's-tail family)
Appl.No 1020040097587 Applicant KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY Inventor KWON, DUR HAN

PURPOSE: An anti-coronavirus composition comprising the extract of Houttuynia cordata Thunberg is provided to treat coronavirus infection diseases including respiratory disease, digestive disease, liver disease, and brain disease in mammals.

CONSTITUTION: The anti-coronavirus composition comprises the extract of Houttuynia cordata Thunberg, wherein the extract of Houttuynia cordata Thunberg is prepared by extracting Houttuynia cordata Thunberg with water of room temperature to 100 deg. C, ethanol or methanol; and the coronavirus is porcine coronavirus, canine coronavirus, bovine coronavirus or SARS(severe acute respiratory syndrome) coronavirus. The health food comprises the extract of Houttuynia cordata Thunberg as an effective ingredient.

© KIPO 2006

6.103156921Application of schisandra chinensis and extracts of schisandra chinensis in resisting severe acute respiratory syndrome (SARS) coronavirus infection
CN 19.06.2013
Int.Class A61K 36/57
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
57Magnoliaceae (Magnolia family)
Appl.No 201110425050.0 Applicant Tianjin International Joint Academy of Biotechnology & Medicine Inventor Rao Zihe
The invention provides the application of schisandra chinensis and extracts of the schisandra chinensis in prevention or treatment of a severe acute respiratory syndrome (SARS) coronavirus infection. When the final concentration of the schisandra chinensis is 500 micrograms per milliliter, the inhibition ratio of isolated SARS coronavirus main protease by 95% ethanol extracts of the schisandra chinensis can reach 92%, and the inhibition ratio of the SARS coronavirus main protease by ethyl acetate extracts of the 95% ethanol extracts of the schisandra chinensis is 89.1%.
7.1020060108163ANTIVIRAL COMPOSITION AGAINST CORONAVIRUS WITHOUT TOXICITY AND SIDE EFFECTS COMPRISING PLANT EXTRACTS SELECTED FROM LAGERSTROEMIA SPECIOSA PARS, SALVIA OFFICINALIS, LAVANDULA OFFICINALIS AND ROSEMARINUS OFFICINALIS
KR 17.10.2006
Int.Class A61K 36/53
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
Appl.No 1020050030359 Applicant KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY Inventor KWON, DUR HAN

PURPOSE: An antiviral composition comprising plant extracts is provided to reduce toxicity and side effects, and improve antiviral activity by inhibiting proliferation of coronavirus, so that infection of coronavirus are prevented or treated.

CONSTITUTION: The antiviral composition comprises the extracts of at least one plant selected from Lagerstroemia speciosa Pars, Salvia officinalis, Lavandula officinalis and Rosemarinus officinalis, wherein the plant extracts are obtained with water as solvent; the composition has antiviral activity against coronavirus; and the coronavirus causes human infection diseases.

© KIPO 2006

8.20060053516Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS
US 09.03.2006
Int.Class A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
Appl.No 11004399 Applicant The University of Hong Kong Inventor Chye Mee Len

The invention relates to genetically modified plants and progeny thereof which constitute edible plant-derived mucosal vaccines and injectable plant-derived mucosal vaccines against Severe Acute Respiratory Syndrome (SARS). The invention relates to a recombinant vector that transforms specifically, but not limited to, the nuclei and/or plastids of tobacco, tomato and lettuce plants for antigen production. In specific embodiments, the plastid transformation vector expressing the nucleotide sequences are pCV1, pCV6 and pCV8, and their derivatives containing an S1 with nucleotide (but not amino acid) changes to optimize codon usage for expression in plants. The present invention relates to methods of making the modified plants which comprises transformation of plants with vectors for nuclear expression and/or plastid expression of nucleotide sequences of the SARS-CoV virus, fragments, derivatives, analogs, or variants thereof. The present invention also relates to methods of immunization against SARS and methods of antibody detection using the SARS-CoV antigens generated by the plastid and/or nuclear vector(s) transformed plants.

9.WO/2007/066991COMPOSITION COMPRISING AN EXTRACT OF CELOSIA FOR PREVENTING AND TREATING HUMAN DISEASE CAUSED BY VIRUSES
WO 14.06.2007
Int.Class A61K 36/21
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
Appl.No PCT/KR2006/005280 Applicant SONG, Chang Seon Inventor SONG, Chang Seon
The present invention relates to a composition comprising an extract of cockscomb for preventing and treating human disease caused by viruses and the use thereof. The extractof cockscomb of the present invention showed anti-viral effect of influenza A viruses, Newcastle disease virus, infectious bronchitis virus, avian pneumovirus, porcine reproductive and respiratory syndrome virus, reticuloendotheliosis virus, Aujeszky's disease virus, adeno virus and Coxsakie virus in vivo and in vitro. Therefore, it can be used as the therapeutics or functional health food for treating and preventing the diseases caused by viral infection.
10.1020180079136METHOD FOR COMPOSING MATERIAL FOR CONTROLLING AVIAN INFLUENZA, SARS, MERS, AND CORONAVIRUS USING MICROENCAPSULATION TECHNOLOGY-APPLIED NATURAL HERB COMPOSITION
KR 10.07.2018
Int.Class A01N 25/28
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
25Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
26in coated particulate form
28Microcapsules
Appl.No 1020160184595 Applicant GREEN T INDUSTRY. CO., LTD.GREEN T INDUSTRY. CO., LTD. Inventor YOO, HAE HYUNYOO, HAE HYUN
The present invention relates to a method for composing a material for preventing and controlling avian influenza, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome coronavirus (MERS), and coronavirus. More specifically, the present invention relates to a method for composing a prevention/control material which shows practical effects by applying dilution rate of raw materials, a microencapsulation technology, and a composition of natural herbs effective in prevention and control. COPYRIGHT KIPO 2018